ANTAGONIST NK-1/NK-3 RECEPTORA ZA LIJEČENJE VALUNGA
- 专利权人:
- NeRRe Therapeutics Limited
- 发明人:
- Trower, Mike
- 申请号：
- HRP20192132
- 公开号：
- HRP20192132T1
- 申请日:
- 2019.11.27
- 申请国别(地区):
- HR
- 年份:
- 2020
- 代理人:
- 摘要：
- This invention relates to new use of dual NK-1/NK-3 receptor antagonists or a pharmaceutically acceptable salt thereof in the treatment of sex-hormone dependent diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Derived 2-oxo-1, 2-dihydroquinol crystal salts and smoked salts containing these crystals； used in drug treatment of diseases related to the dual activity of adrenaline and muscle antagonistic ether receptor
- NOVEL HETEROCYCLYL COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISEASE
- COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST
- CXCR4 receptor antagonist
- USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATED LIVER CANCER
